Explore Sciences, Fortune and more!

Explore related topics

Gilead Sciences, Inc., Celgene Corporation And Biogen Inc: Top 3 Fastest-Growing Biotechs On Fortune 500 List

Gilead Sciences, Inc., Celgene Corporation And Biogen Inc: Top 3 Fastest-Growing Biotechs On Fortune 500 List

Gilead Sciences, Inc. Plans To Expand Its Operations

Gilead Sciences, Inc. Plans To Expand Its Operations

Mesoblast Shoots To A 4-Year High On News Of Celgene Corporation Buying $45 Million Stake

Mesoblast Shoots To A 4-Year High On News Of Celgene Corporation Buying $45 Million Stake

Worst May Be Over For the Biotech Sector

Worst May Be Over For the Biotech Sector

Pfizer Inc. Gets FDA Green Signal For The First Drug To Treat A Rare Lung Disease

Pfizer Inc. Gets FDA Green Signal For The First Drug To Treat A Rare Lung Disease

Merck is getting closer to taking Gilead Sciences head on in the hepatitis C drug category, with news that the former has made crucial progress in its breakthrough therapy treatment.

Merck is getting closer to taking Gilead Sciences head on in the hepatitis C drug category, with news that the former has made crucial progress in its breakthrough therapy treatment.

With small cap biotech companies flooding the news, Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN), and Novartis AG (ADR) (NVS) revealed developments in their businesses. Here is a roundup of what happened in the news for these three pharmaceutical companies

With small cap biotech companies flooding the news, Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN), and Novartis AG (ADR) (NVS) revealed developments in their businesses. Here is a roundup of what happened in the news for these three pharmaceutical companies

Cover Image: Halozyme Therapeutics, Inc. - (HALO)  Down

Cover Image: Halozyme Therapeutics, Inc. - (HALO) Down

Teva Pharmaceutical (TEVA) Sued By VIVUS, Inc. (VVUS) For Qsymia Patent Infringement

Teva Pharmaceutical (TEVA) Sued By VIVUS, Inc. (VVUS) For Qsymia Patent Infringement

Five Below Inc (FIVE) Up 7% After-Hours On Strong Q1 Results and Q2 Projections

Five Below Inc (FIVE) Up 7% After-Hours On Strong Q1 Results and Q2 Projections

Pinterest
Search